NCT02507765View on ClinicalTrials.gov

Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

January 18, 2019

Study Completion Date

January 5, 2021

Conditions
Child-Pugh Class AChild-Pugh Class BStage IIIA Hepatocellular CarcinomaStage IIIB Hepatocellular CarcinomaStage IIIC Hepatocellular CarcinomaStage IVA Hepatocellular CarcinomaStage IVB Hepatocellular Carcinoma
Interventions
OTHER

Laboratory Biomarker Analysis

Correlative studies

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

PROCEDURE

Transarterial Chemoembolization

Undergo TACE

Trial Locations (1)

43210

Ohio State University Comprehensive Cancer Center, Columbus

Sponsors

Collaborators (1)

Varian Medical Systems
All Listed Sponsors
collaborator

Varian Medical Systems

INDUSTRY

lead

Ohio State University Comprehensive Cancer Center

OTHER